Literature DB >> 2448842

Effects of amphetamine, methylphenidate, and apomorphine on regional brain serotonin and 5-hydroxyindole acetic acid.

R Kuczenski1, D S Segal, N J Leith, C D Applegate.   

Abstract

Electrophysiological and cytofluorometric data suggest that doses of amphetamine which enhance locomotor activity and promote focused stereotypies produce pronounced effects on serotonin pathways in the CNS. However, the biochemical evidence regarding changes in serotonergic function produced by moderate doses of this drug is inconsistent. Therefore, the present study was designed to further examine the effects of amphetamine (1-5 mg/kg) on regional brain serotonin and its metabolite and to compare these effects to behaviorally comparable doses of methylphenidate and apomorphine. At doses which produce a multiphasic behavioral response pattern, including a stereotypy phase consisting primarily of repetitive head movements and occasional oral stereotypies, amphetamine (3 mg/kg) and methylphenidate (30 mg/kg) increased levels of 5HIAA in striatum and frontal cortex, two brain regions which receive serotonergic projections from the dorsal raphe nucleus. In contrast, these drugs decreased or had no effect on 5HIAA levels in hippocampus, a brain region which receives its serotonergic innervation from the median raphe nucleus. A moderate dose of apomorphine (0.5 mg/kg) produced a comparable pattern of neurochemical effects. These data are consistent with electrophysiological and cytofluorometric data suggesting enhanced dorsal raphe serotonergic function following amphetamine-like stimulants. Pretreatment of animals with alpha-methyltyrosine at a dose sufficient to prevent the locomotor stimulation and stereotypy promoted by amphetamine, or by haloperidol, failed to prevent the amphetamine-induced increase in 5HIAA, indicating that these serotonergic effects are not secondary to the amphetamine facilitation of dopaminergic transmission.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2448842     DOI: 10.1007/bf00187252

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  38 in total

1.  The precise localization of nigral afferents in the rat as determined by a retrograde tracing technique.

Authors:  B S Bunney; G K Aghajanian
Journal:  Brain Res       Date:  1976-12-03       Impact factor: 3.252

2.  Effect of psychotropic drugs on tryptophan concentration in the rat brain.

Authors:  A Tagliamonte; P Tagliamonte; J Perez-Cruet; S Stern; G L Gessa
Journal:  J Pharmacol Exp Ther       Date:  1971-06       Impact factor: 4.030

3.  Effect of amphetamines on tryptophan concentrations in mice and rats.

Authors:  J Schubert; G Sedvall
Journal:  J Pharm Pharmacol       Date:  1972-01       Impact factor: 3.765

4.  Increased sensitivity to d- and l-amphetamine action after midbrain raphe lesions as measured by locomotor activity.

Authors:  I Lucki; J A Harvey
Journal:  Neuropharmacology       Date:  1979-03       Impact factor: 5.250

5.  Substituted amphetamine derivatives. I. Effect on uptake and release of biogenic monoamines and on monoamine oxidase in the mouse brain.

Authors:  S B Ross; S O Ogren; A L Renyi
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1977-10

6.  Tyrosine hydroxylase activity: regional and subcellular distribution in the brain.

Authors:  D S Segal; R Kuczenski
Journal:  Brain Res       Date:  1974-03-22       Impact factor: 3.252

7.  Differential effects of D- and L-amphetamine and methylphenidate on rat striatal dopamine biosynthesis.

Authors:  R Kuczenski; D S Segal
Journal:  Eur J Pharmacol       Date:  1975-02       Impact factor: 4.432

8.  Effect of sympathomimetic amines on the synaptosomal transport of noradrenaline, dopamine and 5-hydroxytryptamine.

Authors:  M Raiteri; R Del Carmine; A Bertollini; G Levi
Journal:  Eur J Pharmacol       Date:  1977-01-21       Impact factor: 4.432

9.  Reciprocal changes in the firing rate of neostriatal and dorsal raphe neurons following local infusions or systemic injections of D-amphetamine: evidence for neostriatal heterogeneity.

Authors:  G V Rebec; S D Curtis
Journal:  J Neurosci       Date:  1983-11       Impact factor: 6.167

10.  The effects of amfonelic acid on 5-HT metabolism in rat brain.

Authors:  P C Waldmeier; A M Buchle; K Stoecklin; B Fehr; J J Feldtrauer
Journal:  J Neural Transm       Date:  1983       Impact factor: 3.575

View more
  7 in total

1.  Conditioned locomotor activity but not conditioned place preference following intra-accumbens infusions of cocaine.

Authors:  S E Hemby; G H Jones; J B Justice; D B Neill
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

Review 2.  Serotonin and dopamine: unifying affective, activational, and decision functions.

Authors:  Roshan Cools; Kae Nakamura; Nathaniel D Daw
Journal:  Neuropsychopharmacology       Date:  2010-08-25       Impact factor: 7.853

3.  Glutamatergic modulation of hyperactivity in mice lacking the dopamine transporter.

Authors:  R R Gainetdinov; A R Mohn; L M Bohn; M G Caron
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-25       Impact factor: 11.205

4.  Acetyl-L-carnitine reduces impulsive behaviour in adolescent rats.

Authors:  Walter Adriani; Monica Rea; Marta Baviera; William Invernizzi; Mirjana Carli; Orlando Ghirardi; Antonio Caprioli; Giovanni Laviola
Journal:  Psychopharmacology (Berl)       Date:  2004-05-08       Impact factor: 4.530

5.  Dorsal raphe neuronal activities are modulated by methylphenidate.

Authors:  Bin Tang; Nachum Dafny
Journal:  J Neural Transm (Vienna)       Date:  2012-12-27       Impact factor: 3.575

6.  Global 5-HT depletion attenuates the ability of amphetamine to decrease impulsive choice on a delay-discounting task in rats.

Authors:  Catharine A Winstanley; Jeffrey W Dalley; David E H Theobald; Trevor W Robbins
Journal:  Psychopharmacology (Berl)       Date:  2003-09-02       Impact factor: 4.530

Review 7.  Behavioral models of impulsivity in relation to ADHD: translation between clinical and preclinical studies.

Authors:  Catharine A Winstanley; Dawn M Eagle; Trevor W Robbins
Journal:  Clin Psychol Rev       Date:  2006-02-28
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.